Evaluation of proton pump inhibitors and risks of gastric cancer

被引:2
作者
Zeng, Ruijie [1 ,2 ]
Sha, Weihong [1 ]
Wang, Jinghua [3 ]
Zhuo, Zewei [1 ]
Wu, Huihuan [1 ]
Leung, Felix W. [4 ,5 ]
Chen, Hao [1 ]
机构
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China
[2] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
[4] VA Greater Los Angeles Healthcare Syst, Sepulveda Ambulatory Care Ctr, Los Angeles, CA USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
基金
中国国家自然科学基金;
关键词
proton pump inhibition; gastric cancer; ASSOCIATION;
D O I
10.1136/gutjnl-2021-326291
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1924 / 1926
页数:3
相关论文
共 50 条
  • [41] What is the truth about proton pump inhibitors?
    Albarki, Hashm
    Pun, Amy
    Paddle, Paul M.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2020, 28 (06) : 376 - 384
  • [42] Prescription and risks of proton pump inhibitor: fiction and facts
    Koop, Herbert
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (03): : 264 - 274
  • [43] Role of Proton Pump Inhibitors in Laryngopharyngeal Reflux: Clinical Evaluation in a North Indian Population
    Bhargava, Anuja
    Faiz, S. M.
    Srivastava, Mrinal Ranjan
    Shakeel, Mohammad
    Singh, Nafas Jeet
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2019, 71 (03) : 371 - 377
  • [44] Proton Pump Inhibitors and Dementia: Deciphering the Data
    Moayyedi, Paul
    Lewis, Maxine A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (12) : 1809 - 1811
  • [45] Clopidogrel and proton pump inhibitors - boon or bane?
    Labenz, J.
    Meyners, W.
    Petersen, K. -U.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (05) : 203 - 206
  • [46] Proton Pump Inhibitors: Review of Emerging Concerns
    Nehra, Avinash K.
    Alexander, Jeffrey A.
    Loftus, Conor G.
    Nehra, Vandana
    MAYO CLINIC PROCEEDINGS, 2018, 93 (02) : 240 - 246
  • [47] Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers
    Zeng, Ruijie
    Cheng, Yunjiu
    Luo, Dongling
    Wang, Jinghua
    Yang, Jun
    Jiang, Lei
    Zhuo, Zewei
    Guo, Kehang
    Wu, Huihuan
    Leung, Felix W.
    Sha, Weihong
    Chen, Hao
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : 190 - 201
  • [48] Emerging Long-Term Risks of the Use of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers
    Jankovic, Katarina
    Gralnek, Ian M.
    Awadie, Halim
    ANNUAL REVIEW OF MEDICINE, 2025, 76 : 143 - 153
  • [49] Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors
    Joo, Moon Kyung
    Park, Jong-Jae
    Chun, Hoon Jai
    DIGESTIVE DISEASES, 2017, 36 (01) : 1 - 14
  • [50] Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
    Cheung, Ka Shing
    Chan, Esther W.
    Wong, Angel Y. S.
    Chen, Lijia
    Wong, Ian C. K.
    Leung, Wai Keung
    GUT, 2018, 67 (01) : 28 - 35